Invest in Marijuana

Growth in the marijuana industry has been nothing short of phenomenal over the past couple of years, and it shows little sign of slowing down. According to cannabis research firm ArcView, legal marijuana sales in North America increased by 34% to $6.9 billion in 2016, and based on estimates from Cowen & Co., the legal cannabis market could reach $50 billion in the U.S. by 2026. At MOCA we believe that by empowering our communities with this knowledge, they may be motivated to get involved in the cannabis industry whether as business owners, or as investors with the intent of creating generational wealth. The chemical structures of some well-studied cannabinoids between Cannabis varieties could help to bridge the gap between the extensive knowledge on Cannabis that exists within the community of recreational users, and the information needed by medicinal users and health professionals. 

In October 2016, the Australian government legislated to make provisions for the legal cultivation of medicinal cannabis With this change in legislation, Australia enters into the marketplace which is already inhabited by countries such as Italy, Israel, Canada, United States and many others which have legislated to make available medicinal cannabis. Research indicates that the cannabis products have beneficial properties for a series of medical conditions and symptoms including pain, epilepsy, and a number of other clinical conditions. With the birth of this industry, in Australia, opportunities abound investment to produce organic clinically proven medical cannabis. Medicinal Organic Cannabis Australia (MOCA) is positioning to become a producer, cultivator and promoter of the Marijuana industry in Australia and internationally.

At MOCA we are working with leading researchers to study a wide range of (potentially) active components in cannabis plants, visualizing up to 28 different cannabinoids and terpenes. By using this approach, we believe that the endless number of popular varieties (also named ‘cultivars’) can be reduced to a more manageable number of chemically distinct varieties (or ‘chemovars’). 

Further studies into the chemical differences and similarities between the most popular cannabis types may help medicinal users to accurately and efficiently identify the cannabis variety they need most. Exchange of cannabis varieties and information between researchers in different countries that allow medicinal cannabis use, including the Netherlands, Canada and the USA, may greatly facilitate such studies.